Back
Canopy Growth Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
65
CGC
Canopy Growth
Last Price:
5.49
Seasonality Move:
34.7%
Buy
70
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Buy
65
Canopy Growth (CGC)
is a Buy
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [CGC] share price is $5.50. The Score for CGC is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- CGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $331.32. The Score for MDGL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CGC Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $5.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CGC is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $331.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
CGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 61.55 | Buy |
| Chaikin Money Flow: | 2309127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.15 - 5.07) | Buy |
| Bollinger Bands (100): | (4.66 - 6.98) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.42 | Buy |
| Relative Strength Index (14 RSI): | 86.69 | Buy |
| Chaikin Money Flow: | 576514 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.5 - 254.66) | Buy |
| Bollinger Bands (100): | (221.16 - 280.26) | Buy |
CGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.11 | Buy |
| 20-day SMA: | 4.63 | Buy |
| 50-day SMA: | 4.77 | Buy |
| 200-day SMA: | 6.24 | Sell |
| 8-day EMA: | 5.03 | Buy |
| 20-day EMA: | 4.84 | Buy |
| 50-day EMA: | 5.04 | Buy |
| 200-day EMA: | 6.61 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 246.83 | Buy |
| 20-day SMA: | 225.95 | Buy |
| 50-day SMA: | 229.96 | Buy |
| 200-day SMA: | 241.65 | Buy |
| 8-day EMA: | 263.88 | Buy |
| 20-day EMA: | 237.89 | Buy |
| 50-day EMA: | 234.01 | Buy |
| 200-day EMA: | 235.45 | Buy |
Canopy Growth Earnings Growth & CGC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.78 per share, and an increase next year of $0.52 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
Canopy Growth Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||